0001104659-15-012649.txt : 20150220 0001104659-15-012649.hdr.sgml : 20150220 20150220164738 ACCESSION NUMBER: 0001104659-15-012649 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150212 FILED AS OF DATE: 20150220 DATE AS OF CHANGE: 20150220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Selisker Rachel R CENTRAL INDEX KEY: 0001313793 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 15636316 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 a4.xml 4 X0306 4 2015-02-12 0 0000890465 NPS PHARMACEUTICALS INC NPSP 0001313793 Selisker Rachel R 550 HILLS DRIVE BEDMINSTER NJ 07921 1 0 0 0 Restricted Stock Units 2015-02-12 4 A 0 3816 0 A Common Stock 3816 3816 D Each Restricted Stock Unit was awarded under NPS Pharmaceuticals Inc.'s (the "Issuer") amended and restated 2005 Omnibus Incentive Plan and represents a contingent right to receive one share of the Issuer's common stock. One hundred percent of the Restricted Stock Units will vest on the first anniversary of the date of grant. Vested shares will be delivered to the reporting person as soon as administratively practicable following the vesting of the Restricted Stock Units. /s/ Rachel R. Selisker, by Jill Thompson as attorney-in-fact 2015-02-19